Search results
Results from the WOW.Com Content Network
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...
Despite 23andMe’s bleak prognosis, Wojcicki, who has helmed the company since its 2006 founding, has not given up. “I think we can navigate and land this plane,” she told Fortune last month ...
23andMe's board resigned over a "distracting difference of view" with cofounder Anne Wojcicki. The board rejected an earlier proposal by Wojcicki to take the company private.
Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; [2] born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza. She is a co-founder and board member of the Breakthrough Prize.
23andMe CEO Anne Wojcicki co-founded the company in 2006 with biologist Linda Avey and Paul Cusenza, who previously worked at the now-defunct Perlegen Sciences, which was a biotech startup that ...
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
Wojcicki added that 23andMe would immediately be identifying independent directors to join the board. Wojcicki, who holds 49% of the voting power at 23andMe, was the only remaining board member ...
Wojcicki submitted a proposal… The departures leave just one sitting member of the board, its chair, Anne Wojcicki, who co-founded the genetics-testing company in 2006 and serves as its chief ...